GGrantIndex
← Leaderboards

Michael A. Matthay

University Of California San Francisco

Google Scholar ↗PubMed ↗ORCID ↗
$26,142,041
Attributed
$34,172,049
Total exposure
21
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.5M · FY2005–25
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$43,816,437 · 22

By mechanism

P50$11,703,045 · 4
UH3$7,780,995 · 1
U01$7,696,494 · 2
R01$7,462,468 · 3
R37$3,941,200 · 1
N01$2,811,663 · 2

Top collaborators

Most similar at University Of California San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Lung Injury”

Research focus

Lung InjuryLungPulmonary EdemaAlveolarAdult Respiratory Distress SyndromeMortality Vital StatisticsInjuryInsightResearch PersonnelLung Injury, AcuteSamplingClinical ResearchDesignAcuteCellsLiquid SubstanceEpithelialProteinsBaseAcute Respiratory FailureBiological MarkersEdemaCritical IllnessType Ii Epithelial Receptor Cell

Grant awards (81)

Cellular and molecular mapping of ventilator-induced lung injury$666,542
R01 · FY2025 · HL
Cellular and molecular mapping of ventilator-induced lung injury$673,194
R01 · FY2024 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$1,581,887
UH3 · FY2023 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,068,764
UH3 · FY2022 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,064,826
UH3 · FY2021 · HL
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$2,065,518
UH3 · FY2020 · HL
Prevention and Early Treatment of Acute Lung Injury$410,220
U01 · FY2020 · HL · contact PI
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)$1,419,180
UG3 · FY2019 · HL
Prevention and Early Treatment of Acute Lung Injury$415,398
U01 · FY2019 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury$404,324
U01 · FY2018 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury$405,890
U01 · FY2017 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury$410,902
U01 · FY2016 · HL · contact PI
Allogeneic Human Mesenchymal Stem Cells for the Treatment of Acute Lung Injury$1,816,232
U01 · FY2015 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury$438,873
U01 · FY2015 · HL · contact PI
Resolution of Clinical Lung Injury$406,364
R37 · FY2015 · HL · contact PI
Resolution of Clinical Lung Injury$404,302
R37 · FY2014 · HL · contact PI
Allogeneic Human Mesenchymal Stem Cells for the Treatment of Acute Lung Injury$393,420
U01 · FY2014 · HL · contact PI
Prevention and Early Treatment of Acute Lung Injury$148,034
U01 · FY2014 · HL · contact PI
Allogeneic Human Mesenchymal Stem Cells for the Treatment of Acute Lung Injury$1,736,077
U01 · FY2013 · HL · contact PI
Resolution of Clinical Lung Injury$392,751
R37 · FY2013 · HL · contact PI
ARDS - SAILS Protocol$427,482
N01 · FY2012 · HL · contact PI
Resolution of Clinical Lung Injury$420,352
R37 · FY2012 · HL · contact PI
Lung Fluid Balance and Mesenchymal Stem Cells$382,388
R01 · FY2012 · HL · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$125,630
N01 · FY2012 · HL · contact PI
In Vitro and in Vivo Lung Studies$121,868
P01 · FY2012 · AI · contact PI
Allogeneic Human Mesenchymal Stem Cells for the Treatment of Acute Lung Injury$1,117,124
U01 · FY2011 · HL · contact PI
Resolution of Clinical Lung Injury$436,554
R37 · FY2011 · HL · contact PI
Lung Fluid Balance and Mesenchymal Stem Cells$386,250
R01 · FY2011 · HL · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$317,183
N01 · FY2011 · HL · contact PI
In Vitro and in Vivo Lung Studies$146,246
P01 · FY2011 · AI · contact PI
Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome$623,523
N01 · FY2010 · HL · contact PI
Lung Fluid Balance and Mesenchymal Stem Cells$386,250
R01 · FY2010 · HL · contact PI
Resolution of Clinical Lung Injury$375,049
R37 · FY2010 · HL · contact PI
In Vitro and in Vivo Lung Studies$78,256
P01 · FY2010 · AI · contact PI
COMPARATIVE PROTEOMIC INVESTIGATION OF ARDS AND SYSTEMIC INFLAMMATORY INJURY$1,766
P41 · FY2010 · RR · contact PI
Lung Fluid Balance and Mesenchymal Stem Cells$386,250
R01 · FY2009 · HL · contact PI
Resolution of Clinical Lung Injury$375,049
R37 · FY2009 · HL · contact PI
Mechanisms of Transfusion-Induced Lung Injury in$329,470
P50 · FY2009 · HL · contact PI
ARDS - EDEN Protocol$297,905
N01 · FY2009 · HL · contact PI
In Vitro and in Vivo Lung Studies$78,952
P01 · FY2009 · AI · contact PI
COMPARATIVE PROTEOMIC INVESTIGATION OF ARDS AND SYSTEMIC INFLAMMATORY INJURY$5,181
P41 · FY2009 · RR · contact PI
Lung Fluid Balance and Mesenchymal Stem Cells$386,250
R01 · FY2008 · HL · contact PI
Resolution of Clinical Lung Injury$374,746
R37 · FY2008 · HL · contact PI
Mechanisms of Transfusion-Induced Lung Injury in$320,485
P50 · FY2008 · HL · contact PI
In Vitro and in Vivo Lung Studies$121,516
P01 · FY2008 · AI · contact PI
COMPARATIVE PROTEOMIC INVESTIGATION OF ARDS AND SYSTEMIC INFLAMMATORY INJURY$2,642
P41 · FY2008 · RR · contact PI
SCCOR in translational research in Acute Lung Injury$1,893,568
P50 · FY2007 · HL · contact PI
Resolution of Clinical Lung Injury$373,532
R37 · FY2007 · HL · contact PI
ARDS$338,111
N01 · FY2007 · HL · contact PI
Mechanisms of Alveolar Epithelial Fluid Clearance$323,210
R01 · FY2007 · HL · contact PI
Mechanisms of Transfusion-Induced Lung Injury in$318,136
P50 · FY2007 · HL · contact PI
Therapy for Clinical Acute Lung Injury with APC$229,843
P50 · FY2007 · HL · contact PI
COMPARATIVE PROTEOMIC INVESTIGATION OF ARDS AND SYSTEMIC INFLAMMATORY INJURY$665
P41 · FY2007 · RR · contact PI
SCCOR in translational research in Acute Lung Injury$1,980,228
P50 · FY2006 · HL · contact PI
Resolution of Clinical Lung Injury$382,501
R37 · FY2006 · HL · contact PI
Mechanisms of Alveolar Epithelial Fluid Clearance$332,864
R01 · FY2006 · HL · contact PI
Mechanisms of Transfusion-Induced Lung Injury in$324,418
P50 · FY2006 · HL · contact PI
COMPARATIVE PROTEOMIC INVESTIGATION OF ARDS AND SYSTEMIC INFLAMMATORY INJURY$20,829
P41 · FY2006 · RR · contact PI
SCCOR in translational research in Acute Lung Injury$1,983,955
P50 · FY2005 · HL
Mechanisms of Alveolar Epithelial Fluid Clearance$340,875
R01 · FY2005 · HL
Mechanisms of Transfusion-Induced Lung Injury in$316,829
P50 · FY2005 · HL
RESOLUTION OF CLINICAL LUNG INJURY$295,000
R01 · FY2005 · HL
COMPAR PROTEOMICS OF EDEMA FLUIDS IN PATS W/ ARDS &CARDIOGENIC PULMONARY EDEMA$81,532
P41 · FY2005 · RR
SCCOR in translational research in Acute Lung Injury$1,922,855
P50 · FY2004 · HL
COMPAR PROTEOMICS OF EDEMA FLUIDS IN PATS W/ ARDS &CARDIOGENIC PULMONARY EDEMA$341,939
P41 · FY2004 · RR
Mechanisms of Alveolar Epithelial Fluid Clearance$340,875
R01 · FY2004 · HL
RESOLUTION OF CLINICAL LUNG INJURY$295,000
R01 · FY2004 · HL
SCCOR in translational research in Acute Lung Injury$3,788
P50 · FY2004 · HL
SCCOR in translational research in Acute Lung Injury$1,859,994
P50 · FY2003 · HL
Mechanisms of Alveolar Epithelial Fluid Clearance$340,312
R01 · FY2003 · HL
RESOLUTION OF CLINICAL LUNG INJURY$295,000
R01 · FY2003 · HL
Therapy for Clinical Acute Lung Injury with APC$157,108
P50 · FY2003 · HL
Core A- Administrative Core$62,368
P50 · FY2003 · HL
RESOLUTION OF CLINICAL LUNG INJURY$295,000
R01 · FY2002 · HL
MECHANISMS OF ALVEOLAR EPITHELIAL FLUID CLEARANCE$285,461
R01 · FY2002 · HL
CORE--Cell Isolation and Culture Core$0
P01 · FY2002 · AI
RESOLUTION OF CLINICAL LUNG INJURY$295,000
R01 · FY2001 · HL
MECHANISMS OF ALVEOLAR EPITHELIAL FLUID CLEARANCE$279,685
R01 · FY2001 · HL
CCTG CLINICAL NETWORK FOR ARDS TREATMENT--CRITICAL CARE$681,829
N01 · FY2000 · HR
MECHANISMS OF ALVEOLAR EPITHELIAL FLUID CLEARANCE$274,077
R01 · FY2000 · HL
ALVEOLAR EPITHELIAL BARRIER IN CLINICAL LUNG INJURY$202,985
R01 · FY2000 · HL